Centro Ricerche Cliniche Di Verona (Crc)

Verona 37134

0 studies enrolling now · 5 studies all time

What they study most

Advanced Malignancies, Advanced Solid Tumors, Chronic Graft-versus-host Disease, Metastatic Cholangiocarcinoma, Solid Tumor Malignancy, Unresectable Cholangiocarcinoma

Studies at this site

• Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) — Stopped early
• Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced Malignancies — Completed
• GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
• A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation — Stopped early